Loading...
OTCM
AOTXF
Market cap5.04bUSD
Oct 20, Last price  
21.75USD
1D
0.00%
IPO
8.76%
Name

Aptinyx Inc

Chart & performance

D1W1MN
OTCM:AOTXF chart
P/E
13.49
P/S
1.44
EPS
1.61
Vol. 1Y
617.03%
Shs. 5Y
—
Rev. 5Y
-26.37%
Div Yld LY
—
Div Yld TTM
—
Revenues
3.49b
3,490,834,000
Net income
374m
373,776,000
CFO
641m
640,958,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC

Key people

Independent Chairman of the Board · since 2020
Ashish Khanna
Chief Financial Officer, Chief Business Officer · since 2018
Andrew Kidd
Chief Operating Officer · since 2019
Henry O. Gosebruch
Independent Director · since 2019
Independent Director · since 2015
Independent Director · since 2018
Adam M. Koppel
Independent Director · since 2017
Independent Director · since 2016
President, Chief Executive Officer, Director · since 2015
IPO date
Jun 21, 2018
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2026‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT